Thursday, July 16, 2020

Friday, July 17, 2020

Saturday, July 18, 2020

Sunday, July 19, 2020

Thursday, July 16, 2020

11:00-12:30 PM

Registration & Conference Check-In

12:30-12:45 PM

Introduction and Program Overview
Kirkwood F. Adams, Jr., MD

Session I: Current Approaches to the Management of Heart Failure
Moderator: J. Herbert Patterson, PharmD

12:45-1:10 PM

“Old School” But Still Essential Drug Therapies for Heart Failure
Stephanie H. Dunlap, DO

1:10-1:35 PM

Improving Outcomes for Hospitalized Patients with HFrEF: Looking Beyond Stabilization
Kirkwood F. Adams, Jr., MD

1:35-2:45 PM

Optimizing Polypharmacy – Strategies to Resolve Treatment Gaps
: Kirkwood F. Adams, Jr, MD and J. Herbert Patterson, PharmD
Strategies: Neurohormonal Antagonists– Javed Butler, MD, MPH, MBA Aldo Blockade – Marvin Konstam, MD Hydralazine-Nitrate – Alan B. Miller, MD

2:45-3:10 PM

Synthesizing Evidence-Based Medicine and Clinical Acumen in CHF Care
Hector O. Ventura, MD

3:10-3:25 PM


3:25-3:50 PM

Pulmonary Arterial Hypertension: Latest Concepts in Evaluation and Treatment
Lisa J. Rose-Jones, MD

3:50-4:15 PM

CHF With Preserved EF – What’s Wrong with the Heart and Circulation?
Peter E. Carson, MD

4:15-4:40 PM

Clinical Challenges: Therapeutic Concepts in Heart Failure with Preserved EF
Marvin Konstam, MD

4:40-5:30 PM

Making Polypharmacy Work in the Clinic – Case Vignettes with Discussion
Case Presenters:
Douglas D. Schocken, MD and Paul J. Hauptman, MD
Case Discussants: Stephanie H. Dunlap, DO, Robert L. Page, II, PharmD, Hector O. Ventura, MD, and Carla A. Sueta, MD, PhD

Friday, July 17, 2020

7:30-8:30 AM

Breakfast and Check-In

Session II: Electrophysiological Approaches to Heart Failure
Moderator: Alan B. Miller, MD

8:30-8:55 AM

Electrophysiologist’s Perspective: How Can Implantable Cardiac Rhythm Management Devices Help My Heart Failure Patients?
Anil K. Gehi, MD

8:55-9:20 AM

Heart Failure Specialist Perspective: EP Devices – Who, When and What?
Alan B. Miller, MD

9:20-9:30 AM

EP Panel Discussion
Discussants:  Alan B. Miller, MD, Anil K. Gehi, MD, and Mathew Baker, MD

9:30-9:45 AM


Session III: Surgical Strategies for Heart Failure
Moderator: Patricia P. Chang, MD, MHS

9:45-10:10 AM

Ventricular Assist Devices: Latest Strategies for Optimal Clinical Application
Christopher V. Chien, MD

10:10-10:35 AM

Mitral Regurgitation: Causes, Natural History, Classic and Novel Interventions
JoAnn Lindenfeld, MD

10:35-11:00 AM

Real World Insights on Cardiac Assist Devices and Transplantation
James B. Young, MD

11:00-11:40 AM

Surgical Approaches to Advanced Heart Failure: Patient Selection and Timing
Patricia P. Chang, MD, MHS
Case Presenter: Sudha Jaganathan, MD
Discussant: James C. Fang, MD
Panelists: James B. Young, MD, Christopher V. Chien, MD, JoAnn Lindenfeld, MD, and William T. Abraham, MD

Hot Topic: Heart Failure with Preserved Ejection Fraction: Changing Landscape and Therapy?

11:40-12:20 PM

Mechanistic Concepts in HFpEF: Insights from ARNI Rx, Biomarkers and Echo Findings
Kirkwood F. Adams, Jr., MD
Speakers: James L. Januzzi, Jr., MD and Michael Zile, MD
Panelists: Peter P. Liu, MD, Christopher M. O’Connor, MD, David E. Lanfear, MD, and Mona Fiuzat, PharmD

12:20-12:30 PM

Lunch Pick-Up

12:30-1:30 PM

Lunch and Featured Panel Discussion: Treatment Options for Mitral Regurgitation: Focus on COAPT Trial
Patricia P. Chang, MD, MHS
Speaker: William T. Abraham, MD
Commentary: JoAnn Lindenfeld, MD, Christopher V. Chien, MD, and James C. Fang, MD

1:30-2:30 PM | Concurrent Workshops

Nursing Challenges in Caring for the Chronic Heart Failure Patient
Jana M. Glotzer, MSN, ACNP, Carla J. Pies, MSN, ARNP, Sarah Waters, ANP-BC, Carrie Neal, RN, BSN, and Tammy Long, AGNP, MSN, RN, CCRN

Optimizing Patient Selection for EP Device and Intervention Therapy
Anil K. Gehi, MD and Mathew Baker, MD

Unusual Cardiomyopathies: Approaches to Evaluation and Management
Kirkwood F. Adams, Jr., MD, Mirnela Byku, MD, PhD, and Uri Elkayam, MD

Case-Based Interactive Discussion: How to Do an Effective Heart Failure History and Physical
Douglas D. Schocken, MD

Clinical Update on Cardio-Oncology
Daniel J. Lenihan, MD, Brian C. Jensen MD, and Jo Ellen Rodgers, PharmD

Saturday, July 18, 2020

7:15-8:15 AM

Breakfast & Check-In

Session IV: Future Directions in Heart Failure Therapy: Biomarkers and Late Breaking Trials
Moderator: Kirkwood F. Adams, Jr., MD

8:15-8:40 AM

Personalizing Medicine in Heart Failure – Revisiting the Role of Genomics
David E. Lanfear, MD

8:40-9:05 AM

Omics and Latest Insights Into the Pathophysiology of Heart Failure
Peter P. Liu, MD

9:05-9:15 AM

Q&A/Panel Discussion

9:15-9:55 AM

Advances in Diagnosis and Treatment of Cardiac Amyloid: Key Role Novel Drug Therapy
Mathew S. Maurer, MD and Alan B. Miller, MD

9:55-10:10 AM


10:10-10:35 AM

Guanylate Cyclase Stimulation-Vericiguat: Insights VICTORIA and VITALITY-HFpEF Trials
Christopher M. O’Connor, MD

10:35-11:00 AM

Latest Insights Into Pharmacologic Enhancement of Ventricular Function in CHF
Kirkwood F. Adams, Jr., MD

11:00-11:25 AM

Novel Investigation of Classical Diuretics: Mechanisms and Outcomes
Eric J. Velazquez, MD and Jeff Testani, MD

11:25 -11:55 AM

CHF and Diabetes Treatment Intersection – SGLT2 Inhibitors to Improve CV Outcomes
Javed Butler, MD, MPH, MBA

11:55-12:20 PM

Update on Novel Therapeutic Approaches to Heart Failure
Barry Greenberg, MD

12:20-12:30 PM

Lunch Pick-Up

12:30-1:30 PM

Lunch and Featured Panel Discussion: Potential Opportunities and Challenges of Vericiguat and SGLT2 Inhibitors as Components of the Polypharmacy of Heart Failure: Latest Clinical Perspectives
Speakers: Christopher M. O’Connor, MD and Javed Butler, MD, MPH, MBA
Moderator: Kirkwood F. Adams, Jr., MD
Panelists: Ileana L. Piña, MD, MPH, David Lanfear, MD, Barry Greenberg, MD, and Robert J. Mentz, MD

1:30-2:30 PM | Concurrent Workshops

Pharmacotherapeutic Challenges in Treating the Heart Failure Patient
Robert L. Page II, PharmD, Barry E. Bleske, PharmD, and Erika Giblin, PharmD

Advanced and Refractory HF: Individualizing LVAD and Hemodynamic Monitoring Strategies
Robert T. Cole, MD, Elizabeth Volz, MD, Lauren B. Cooper, MD, and Megan Andrews, ANP

Approaches to Challenging Patients: Case Vignettes: Exercise Rehabilitation
Ileana L. Piña, MD, MPH and Beth S. Rosenberg, MD, EdD

Optimizing Therapy in HF Patients with Sleep Disordered Breathing
William G. Cotts, MD

Defining the Role of Palliative Care and End of Life Management in CHF Patients
Robert J. Mentz, MD and Carla J. Pies, MSN, ARNP

Sunday, July 19, 2020

7:30-8:00 AM

Breakfast & Check-in

Session V: Clinical Science to Clinical Care – Making it Happen in the CHF Clinic
Moderator: Kirkwood F. Adams, Jr., MD

8:00-8:35 AM

Optimizing Care in Heart Failure – Process Matters
Ileana L. Piña, MD, MPH

8:35-9:25 AM

The Team Approach to Heart Failure Patient Management
: Ileana L. Piña, MD, MPH
Panel Discussion: Jana M. Glotzer, MSN, ACNP, Katherine Di Palo, PharmD, and Erika Giblin, PharmD

Addressing Co-Morbidities in CHF: Current Approaches to Diabetes and Atrial Fibrillation

9:25-9:50 AM

Novel Diabetic Drugs – Potential Mechanisms for CV Benefit
Kirkwood F. Adams, Jr.

9:50-10:20 AM

Novel Diabetic Drugs – Favorable Clinical Outcomes vs. Risk in Key CV Populations
Robert J. Mentz, MD

10:20-10:50 AM

Atrial Fibrillation: Consequences and Therapeutic Implications in CHF
Anil K. Gehi, MD

10:50-11:10 AM

Panel Discussion: Kirkwood F. Adams, Jr., MD, Robert J. Mentz, MD, and Anil K. Gehi, MD

11:10-12:00 PM

Clinical Conundrums: Decision Making in Challenging CHF Cases
Kirkwood F. Adams, Jr., MD
Panelists: Ileana L. Piña, MD, MPH and Hector O. Ventura, MD

12:00 PM



Share on Social Media! #HFM2020